Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Next round of financing

<< Previous

Bullboard Posts

Next >>

Comment by SouthernTierTomon Mar 09, 2022 7:45am

158 Views

Post# 34498446

RE:RE:RE:RE: Next round of financing

WOW!! .... this must be a very low cost operator. It was my belief they had less than 3M CAD in the kitty and well... with losses and a costly FDA trial underway it would be very impressive it the next round of financing could be pusehed that far back. I will watch closely and hope that these 2023 estimates do in fact play out as per the bullboard's direction. I hope the "bullboard" is right "this time" .... those 55 cent CAD shares must have been particularly pricey the last time everyone ( all three of you ) got sooo bullbiah.

GLTA!!

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario